sales@scalarmarketresearch.com |  +1-800-213-5170  (U.S./ Canada Toll-free) |  REGISTER |  SIGN IN

Home >> Reports >> hematologic malignancies market

report

Hematologic Malignancies Market, by Type (Leukemia, Lymphoma, Multiple Myeloma, Others), Therapy (Chemotherapy, Radiotherapy, Immunotherapy, Stem Cell Transplantation, Others) – Global Revenue, Trends, Growth, Share, Size and Forecast to 2022

HC413 October 2017 100+ FREE 10% CUSTOMIZATION

Blood malignancies are one of the most common reasons of occurrence of blood cancer leading to increasing number of deaths across the world. Leukemia, lymphoma and multiple myeloma are the three most common types of blood cancers. Slowly there is an increasing awareness among healthcare professionals about the early detection and treatment of cancer. This is pressurizing the government to increase the funding for research and development activities, which is boosting the growth of the hematologic malignancies market further. This report studies the current and future aspects of the hematologic malignancies market.

The report tracks the major market events including product launches, technological developments, mergers & acquisitions, and the innovative business strategies opted by key market players. Along with strategically analyzing the key micro markets, the report also focuses on industry-specific drivers, restraints, opportunities and challenges in the hematologic malignancies market. The scope of this report covers the hematologic malignancies market by its major segments, which include the types, applications, and the major geographic regions.

KEY BENEFITS OF THE REPORT

  • In-depth analysis of the market ecosystem and its impact on the revenue growth
  • Understanding of the strategies that are being adopted by the key players in this market to stay competitive
  • Valuable insights into the key technological and market trends impacting this market

KEY PREMIUM INDUSTRY INSIGHTS

  • The hematologic malignancies market is growing at a rapid pace during the forecasted period mainly because of rise in number of patients suffering from blood cancer around the world. Due to this there is also an increasing focus on development of new treatments for cancer, which is promoting the market growth.
  • The key market players in the oncology sector are collaborating and entering into partnerships and acquisitions to develop new treatment techniques which are creating more growth opportunities for the hematologic malignancies market. The new regulatory policies required for new drugs approval is driving the market growth further.

The global hematologic malignancies market is divided into four major geographical segments which are North America, Europe, Asia-Pacific, and Rest of the World (RoW). The North America region holds the highest market share of the hematologic malignancies market and proves to be the largest revenue contributor. The region continues to dominate the global market during the forecasted period because of availability of large number of key players, well-established healthcare infrastructure, and presence of effective drugs for treatment of blood malignancies. The Asia-Pacific region is also growing at a fast pace because of increasing expenditure on healthcare infrastructure to fulfill patient needs, and rising awareness among people for early diagnosis and treatment for cancer. In addition, there is also availability of effective treatment options in emerging economies like India and China, which is favoring the progress of the hematologic malignancies market in this region.

RESEARCH METHODOLOGY

The research methodology for Scalar Market Research’s hematologic malignancies market report utilizes a combination of top-down and bottom-up research formats. Our primary focus on continuous market tracking, rigorous fact-checking, data-triangulation, and multiple layers of quality control ensures high-quality data that can be leveraged for actionable research insights.

To know about the assumptions considered for the study, Download PDF Sample.

MARKET SEGMENTATION

This report analyzes the hematologic malignancies market by the following segments:

  • Hematologic Malignancies Market, by Type
    • Leukemia
    • Lymphoma
    • Multiple Myeloma
    • Others
  • Hematologic Malignancies Market, by Therapy
    • Chemotherapy
    • Radiotherapy
    • Immunotherapy
    • Stem Cell Transplantation
    • Others

KEY MARKET PLAYERS

Key players in the hematologic malignancies market include:

  • Pfizer Inc.
  • F. Hoffmann-LA Roche Ltd
  • Sanofi
  • Bristol-Myers Squibb Company
  • AbbVie Inc
  • Novartis AG
  • GlaxoSmithKline PLC.
  • Celgene Corporation
  • Johnson & Johnson Services, Inc.
  • Takeda Pharmaceutical Company

GEOGRAPHIC COVERAGE AND ANALYSIS

This granular market research report covers the following geographic regions in great detail:

  • NORTH AMERICA
    • U.S.
    • Rest of North America
  • EUROPE
    • France
    • Germany
    • U.K
    • Rest of Europe
  • ASIA-PACIFIC
    • China
    • India
    • Japan
    • Rest of Asia-Pacific
  • REST OF THE WORLD
    • Latin America
    • Middle East & Africa

TRENDING RELATED REPORT

Blood Pressure Monitors Market, by Types (Sphygmomanometers, Automated Blood Pressure Monitors, Ambulatory Blood Pressure Monitor, Blood Pressure Transducers, and Blood Pressure Accessories), Technologies (Digital, Aneroid, and Wearable), End-users (Home Healthcare, Hospitals, and Diagnostic Centers) - Global Revenue, Trends, Growth, Share, Size and Forecast to 2022


  1. MARKET OVERVIEW
    1. Market Definitions
    2. Research Methodology
    3. Market Segmentation
  2. EXECUTIVE SUMMARY
  3. MARKET DYNAMICS
    1. Drivers
    2. Restraints
    3. Opportunities
    4. Premium Industry Trends
  4. INDUSTRY ANALYSIS
    1. Value Chain Analysis
  5. HEMATOLOGIC MALIGNANCIES MARKET, BY TYPE
    1. Segment Share
    2. By Type
      1. Leukemia
      2. Lymphoma
      3. Multiple Myeloma
      4. Others
  6. HEMATOLOGIC MALIGNANCIES MARKET, BY THERAPY
    1. Segment Share
    2. By Therapy
      1. Chemotherapy
      2. Radiotherapy
      3. Immunotherapy
      4. Stem Cell Transplantation
      5. Others
  7. HEMATOLOGIC MALIGNANCIES MARKET, BY GEOGRAPHY
    1. Segment Share
    2. North America
      1. By Regions
        1. U.S.
        2. Rest of North America
      2. By Type
      3. By Therapy
    3. Europe
      1. By Regions
        1. France
        2. Germany
        3. U.K.
        4. Rest of Europe
      2. By Type
      3. By Therapy
    4. Asia-Pacific
      1. By Regions
        1. China
        2. India
        3. Japan
        4. Rest of Asia-Pacific
      2. By Type
      3. By Therapy
    5. Rest of the World
      1. By Regions
        1. Latin America
        2. Middle East & Africa
      2. By Type
      3. By Therapy
  8. COMPETITIVE LANDSCAPE
    1. Market Positioning of Key Players, 2016
  9. KEY MARKET PLAYERS
    1. Pfizer Inc.
      1. Overview
      2. Key Strategies
      3. Key Developments
    2. F. Hoffmann-LA Roche Ltd
      1. Overview
      2. Key Strategies
      3. Key Developments
    3. Sanofi
      1. Overview
      2. Key Strategies
      3. Key Developments
    4. Bristol-Myers Squibb Company
      1. Overview
      2. Key Strategies
      3. Key Developments
    5. AbbVie Inc.
      1. Overview
      2. Key Strategies
      3. Key Developments
    6. Novartis AG
      1. Overview
      2. Key Strategies
      3. Key Developments
    7. GlaxoSmithKline PLC.
      1. Overview
      2. Key Strategies
      3. Key Developments
    8. Celgene Corporation
      1. Overview
      2. Key Strategies
      3. Key Developments
    9. Johnson & Johnson Services, Inc.
      1. Overview
      2. Key Strategies
      3. Key Developments
    10. Takeda Pharmaceutical Company
      1. Overview
      2. Key Strategies
      3. Key Developments
  10. SCALAR 360 DEGREE MARKET PERSPECTIVE
  11. APPENDIX
Please submit your enquiry below so our representative can get in touch with you
*
*
*
*
*
*

USA - CANADA TOLL FREE
+1-800-213-5170

EMAIL
sales@scalarmarketresearch.com

Benefits of Buying From Scalar

Unparalleled Expertise

Our industry experts hold inimitable know-how across wide range of industry verticals

Assured Quality

We deliver high-quality, real-time and data-driven industry insights to our clients

24x7 Analyst Support

We offer pre-purchase and post-purchase support from our industry experts

Privacy & Security

All your personal information and confidential details are safe and secure with us